Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2103 studies found for:    Squamous Cell Carcinoma
Show Display Options
Rank Status Study
1 Recruiting Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer
Condition: Head and Neck Cancer
Intervention: Other: Non-interventional study
2 Completed Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients
Condition: Squamous Cell Carcinoma
Intervention:
3 Recruiting A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western Kenya
Condition: Esophageal Squamous Cell Carcinoma
Intervention:
4 Completed Microarray Analysis of microRNA Expression Profiles in Cutaneous Squamous Cell Carcinoma
Condition: Cutaneous Squamous Cell Carcinoma
Intervention:
5 Completed Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Erlotinib;   Drug: Erlotinib plus sulindac;   Drug: Placebo
6 Completed Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC
Conditions: Squamous Cell Carcinoma;   Non-Small Cell Lung Cancer
Intervention: Drug: Erlotinib + Rosuvastatin
7 Terminated Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma
Interventions: Drug: Azacitidine;   Drug: Cisplatin
8 Completed Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma;   Carcinoma of Head/Neck
Interventions: Drug: Taxotere;   Drug: Cisplatin;   Drug: 5-Fluorouracil;   Drug: Leucovorin;   Drug: G-CSF;   Drug: Ciprofloxacin
9 Unknown  The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy
Conditions: Adenocarcinoma;   Squamous Cell Carcinoma;   Relevant Condition Terms to the Conditions Field
Intervention: Radiation: CT, radiation therapy
10 Suspended Identification of Breath Biomarkers in Head and Neck Squamous Cell Carcinoma
Conditions: Oral Cavity Squamous Cell Carcinoma;   Oropharyngeal Squamous Cell Carcinoma
Intervention:
11 Unknown  Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma
Interventions: Drug: Nedaplatin;   Drug: Cisplatin;   Drug: Docetaxel
12 Recruiting Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung
Condition: Non-small Cell Lung Cancer
Intervention: Drug: nanoparticle albumin-bound paclitaxel/carboplatin
13 Not yet recruiting Quantitative Optical Sensor Findings in Head & Neck Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma
Intervention: Device: No intervention, this is an observational study
14 Recruiting Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
Condition: Locally Advanced Thoracic Middle-lower Segment Esophageal Squamous Cell Carcinoma
Interventions: Radiation: preoperative radiotherapy;   Drug: cetuximab
15 Completed Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Interventions: Drug: Bevacizumab;   Drug: erlotinib;   Drug: Sulindac
16 Completed A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Drug: PF-00299804
17 Unknown  Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck
Condition: Squamous Cell Carcinoma of Head and Neck
Intervention: Drug: Pemetrexed
18 Completed Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Condition: Esophageal Squamous Cell Carcinoma
Interventions: Drug: LJM716;   Drug: BYL719;   Drug: Paclitaxel;   Drug: Docetaxel;   Drug: Irinotecan
19 Enrolling by invitation Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell Carcinoma
Conditions: Oral Squamous Cell Carcinoma;   Oral Epithelial Dysplasia
Intervention:
20 Active, not recruiting Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx
Condition: Squamous Cell Carcinoma of Oropharynx
Interventions: Radiation: IMRT;   Drug: Cisplatin;   Drug: Carboplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.